Adial Pharmaceuticals Announces Name Change to Azora Therapeutics and New Executive Team, Focused on Advancing AT177, an Oral, Colon-Targeted AhR Agonist for Ulcerative Colitis

Stockholders approved the conversion of the preferred stock issued in the June 2026 acquisition of Azora Therapeutics Azora’s common stock...

As Senior Care Costs Approach $100,000 to $160,000 Annually by 2030, Electronic Caregiver Offers AI-Driven Home Care Support for About $10 a Day

With traditional aging-care expenses climbing beyond the reach of millions of American families, Addison Care introduces an affordable combination of...

Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator Licenses SpeechDx Dataset to Eli Lilly and Company, Advancing Speech-Based Markers as a Critical Alzheimer’s Research Tool

Lilly's partnership signals growing industry recognition of AI-driven speech analysis as a path to predicting Alzheimer's disease riskNEW YORK, Oct....

error: Content is protected !!